IOL Chemicals and Pharmaceuticals Share Price

₹ 180.24

+₹2.59 (1.46%)

Last updated 02 Nov, 2026, 15:58 IST

NSE: IOLCP

IOL Chemicals and Pharmaceuticals Share Price Today

As of 3 Nov 2026, IOL Chemicals and Pharmaceuticals share price is ₹180.24. The stock opened at ₹179.90, compared to its previous close of ₹177.65. During today's trading session, IOL Chemicals and Pharmaceuticals share price moved in the range of ₹174.72 to ₹183.70, with an average price of ₹179.21 for the day. Looking at its last 52-week, the stock has touched a low of ₹67.19 and a high of ₹224.00. On the performance front, IOL Chemicals and Pharmaceuticals share price has increased by 91.09% over the last six months and is up 94.79% on a year-on-year basis.

₹174.72

1.46% up today

₹183.70

1D LOW

1D HIGH

IOL Chemicals and Pharmaceuticals Stock Insights

Latest Earning

Op Profit TrendUp by 0.69% QoQ

Latest Earning

Net Profit TrendUp by 1.04% QoQ

Latest Earning

Revenue TrendUp by 4.72% QoQ

Stock Performance

OutperformingBeat Nifty by 26.86 % in last 3 month

Shareholding Pattern

DIIDII decreased stake by 97.05%

Shareholding Pattern

FIIFII increased stake by 48.86%

IOL Chemicals and Pharmaceuticals Stock Insights

Latest Earning

Op Profit TrendUp by 0.69% QoQ

Latest Earning

Net Profit TrendUp by 1.04% QoQ

Latest Earning

Revenue TrendUp by 4.72% QoQ

Stock Performance

OutperformingBeat Nifty by 26.86 % in last 3 month

Shareholding Pattern

DIIDII decreased stake by 97.05%

Shareholding Pattern

FIIFII increased stake by 48.86%

IOL Chemicals and Pharmaceuticals stock performance
Open	₹179.90
High	₹183.70
Low	₹174.72
Prev. close	₹177.65

IOL Chemicals and Pharmaceuticals trading activity
Volume	43,11,251
Average traded price	₹179.70
Last traded time	03:58:44 02 Nov
Last traded quantity	50

₹142.12₹213.18

Circuit Low

Circuit High

₹67.19₹224.00

52-Week Low

52-Week High

Circuit

₹142.12

₹213.18

52-week

₹67.19

₹224.00

Mkt Cap Cr

5,217.45

P/E

31.02

P/B

2.9

ROA

7.18%

ROE

10.55%

ROCE

13.55%

Quick Ratio

1.24

EV/EBITDA

13.84

Mkt Cap Cr

5,217.45

P/E

31.02

P/B

2.9

ROA

7.18%

ROE

10.55%

ROCE

13.55%

Quick Ratio

1.24

EV/EBITDA

13.84

Based on fundamentals, this stock's

Performance

Very Poor

IOL Chemicals has not beaten FD return of 7%

Valuation

Overvalued

IOL Chemicals appears overvalued compared to its peers

Earnings

Excellent

IOL Chemicals revenue, operating profit and net profit are growing

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROA	ROE	ROCE	Quick Ratio	EV/EBITDA
Sun Pharmaceutical Industries	4,26,661.74	38.83	4.78	9.61%	13.79%	18.65%	2.31	22.27
Divis Laboratories	2,57,902.73	88.17	15.39	14.6%	15.32%	19.56%	3.5	58.97
Torrent Pharmaceuticals	1,76,306.21	84.0	9.6	4.7%	11.42%	11.37%	0.75	33.6
Laurus Labs	1,29,242.68	97.0	21.33	11.58%	22.11%	20.91%	0.68	54.77
Zydus Lifesciences	1,24,089.48	27.02	4.58	8.57%	18.59%	17.35%	0.91	16.42
Dr. Reddy's Laboratories	1,12,698.53	40.84	2.9	4.79%	7.21%	8.58%	1.35	19.05
Cipla	1,11,486.14	39.06	3.15	6.6%	8.18%	10.8%	2.5	21.03
Mankind Pharma	1,02,796.60	45.42	5.85	7.82%	12.76%	14.68%	0.74	25.01
Aurobindo Pharma	96,536.90	26.02	2.55	6.34%	9.25%	11.76%	1.15	12.38
Lupin	91,870.16	16.55	4.09	14.47%	23.76%	24.88%	1.42	9.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

IOL Chemicals and Pharmaceuticals Company Background

ISIN

INE485C01029

Sector Market Cap

₹ 5,217.45 Cr

IOL Chemicals and Pharmaceuticals Limited is engaged in manufacturing and selling of pharmaceutical and chemical products. The Company operates through two segments: Chemical and Pharmaceutical. The Chemical segment produces and sells Ethyl Acetate, Iso Butyl Benzene, Acetyl Chloride, Mono Chloro Acetic Acid, Para Amino Phenol (PAP), and others. The Pharmaceutical segment produces and sells various active pharma ingredients (API) including Ibuprofen, Metformin, Fenofibrate, Lamotrigine, Clopidogrel Bisulphate, Pantoprazole, Gabapentin, Paracetamol, and others. Its API product portfolio includes Pantoprazole Sodium, Clopidogrel Bisulphate (Form II), Losartan Potassium, Levetiracetam, and Fenofibrate (Micronised). Its Specialty Chemical division includes Ethyl Acetate, Iso Butyl Benzene, Mono Chloro acetic Acid, and Acetic Anhydride. Its Ethyl Acetate is used in industries like flexible packaging, pharmaceuticals, ink, food processing, pesticides, and the paint industry.

IOL Chemicals and Pharmaceuticals Financial Highlights

Revenue: IOL Chemicals and Pharmaceuticals reported revenue of ₹2,340.44 crore in FY26 vs ₹2,101.62 crore in FY25. It showed an increase of 11.36% on a yearly basis.
Operating Profit: IOL Chemicals and Pharmaceuticals reported an operating profit of ₹184.36 crore in FY26 vs ₹137.96 crore in FY25. It showed an increase of 33.63% on a year-on-year basis.
Net Profit: IOL Chemicals and Pharmaceuticals reported a net profit of ₹137.64 crore in FY26 vs ₹101.07 crore in FY25. It showed an increase of 36.18% on a yearly basis.

IOL Chemicals and Pharmaceuticals Quarterly Result Highlights

IOL Chemicals and Pharmaceuticals reported revenue of ₹800.54 crore in Sep 2026, compared with ₹764.44 crore in Jun 2026, representing an increase of 4.72% on a quarter-on-quarter (QoQ) basis.
IOL Chemicals and Pharmaceuticals reported an operating profit of ₹87.29 crore in Sep 2026, compared with ₹86.69 crore in Jun 2026, representing an increase of 0.69% on a quarter-on-quarter (QoQ) basis.
IOL Chemicals and Pharmaceuticals reported a profit of ₹65.07 crore in Sep 2026, compared with ₹64.40 crore in Jun 2026, reflecting an increase of 1.04% on a QoQ basis.
The earnings per share (EPS) of IOL Chemicals and Pharmaceuticals stood at ₹4.69 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters

62.28%

FII

7.25%

Other DII

0.01%

Retail and other

30.17%

Mutual funds

0.29%

Foreign Institutional Investor (FII)

FII shareholding by period
Dec 2025	2.08%
Mar 2026	1.72%
Jun 2026	4.87%
Sep 2026	7.25%

IOL Chemicals and Pharmaceuticals Investment Returns

1 day

+1.46%

1 week

+7.30%

1 month

-13.92%

1 year

+94.79%

3 years

+111.92%

5 years

+62.67%

IOL Chemicals and Pharmaceuticals Share Price History

IOL Chemicals and Pharmaceuticals share price history by day, showing open and close prices and the percentage change
Day	Open / Close	Change %
02 Nov 26	₹179.90 / ₹180.24	+1.46%
30 Oct 26	₹186.40 / ₹177.65	-3.94%
29 Oct 26	₹181.00 / ₹184.93	+2.39%
28 Oct 26	₹180.00 / ₹180.62	+0.70%
27 Oct 26	₹168.60 / ₹179.36	+6.77%
26 Oct 26	₹158.00 / ₹167.98	+2.34%
23 Oct 26	₹169.20 / ₹164.14	-4.21%
22 Oct 26	₹172.10 / ₹171.36	-1.65%
21 Oct 26	₹183.24 / ₹174.24	-4.85%
19 Oct 26	₹194.68 / ₹183.13	-5.94%

IOL Chemicals and Pharmaceuticals Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Revenue	₹2,319.06	₹2,079.21	₹2,132.79	₹2,217.11
Other Income	₹21.38	₹22.41	₹30.07	₹25.61
Total Revenue	₹2,340.44	₹2,101.62	₹2,162.86	₹2,242.72
Total Expenses	₹2,144.87	₹1,963.66	₹1,981.21	₹2,054.07
Profit Before Tax	₹184.36	₹137.96	₹181.65	₹188.65
Tax	₹46.72	₹36.89	₹47.22	₹49.51
Profit After Tax	₹137.64	₹101.07	₹134.43	₹139.14
EPS - Basic	₹4.69	₹3.44	₹4.58	₹23.70
EPS - Diluted	₹4.69	₹3.44	₹4.58	₹23.70

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Profit before tax	₹184.36	₹137.96	₹181.65	₹188.65
Income before WC changes	₹269.40	₹217.81	₹241.47	₹233.06
Change in Assets	-₹83.91	₹25.18	-₹71.66	₹41.30
Change in Liabilities	₹66.69	-₹46.05	₹161.99	-₹104.99
Change in WC	-₹17.22	-₹20.87	₹90.33	-₹63.69
Cash flow from Operations	₹214.32	₹178.62	₹289.78	₹122.27
Cash flow from Investing	-₹198.11	-₹154.18	-₹190.98	-₹120.00
Cash flow from Financing	-₹29.03	₹46.04	-₹92.50	-₹4.11
Total Cash Flow	-₹12.82	₹70.48	₹6.30	-₹1.84
Cash (Start of the year)	₹78.17	₹7.69	₹1.39	₹3.23
Cash (End of the year)	₹65.35	₹78.17	₹7.69	₹1.39

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Non-Current Assets	₹1,359.32	₹1,230.73	₹1,124.63	₹1,101.74
Current Assets	₹1,227.63	₹1,151.34	₹1,119.77	₹920.39
Total Assets	₹2,586.95	₹2,382.07	₹2,244.40	₹2,022.13
Current Liabilities	₹690.18	₹609.91	₹560.00	₹456.26
Net Current Asset	₹537.45	₹541.43	₹559.77	₹464.13
Non-Current Liabilities	₹98.22	₹84.50	₹72.89	₹58.15
Equity Capital	₹1,798.55	₹1,687.66	₹1,611.51	₹1,507.72
Total Equity & Liabilities	₹2,586.95	₹2,382.07	₹2,244.40	₹2,022.13

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Revenue	₹2,319.06	₹2,079.21	₹2,132.79	₹2,217.11
Other Income	₹21.28	₹22.40	₹30.07	₹25.57
Total Revenue	₹2,340.34	₹2,101.61	₹2,162.86	₹2,242.68
Total Expenses	₹2,144.69	₹1,963.72	₹1,980.22	₹2,053.19
Profit Before Tax	₹184.44	₹137.89	₹182.64	₹189.49
Tax	₹46.72	₹36.89	₹47.22	₹49.51
Profit After Tax	₹137.72	₹101.00	₹135.42	₹139.98
EPS - Basic	₹4.69	₹3.44	₹4.61	₹23.84
EPS - Diluted	₹4.69	₹3.44	₹4.61	₹23.84

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Profit before tax	₹184.44	₹137.89	₹182.64	₹189.49
Income before WC changes	₹269.52	₹217.67	₹242.40	₹233.91
Change in Assets	-₹83.79	₹25.18	-₹71.90	₹41.67
Change in Liabilities	₹66.55	-₹45.85	₹161.98	-₹105.34
Change in WC	-₹17.24	-₹20.67	₹90.08	-₹63.67
Cash flow from Operations	₹214.42	₹178.68	₹290.46	₹123.14
Cash flow from Investing	-₹198.12	-₹154.23	-₹191.39	-₹119.19
Cash flow from Financing	-₹29.03	₹46.04	-₹92.50	-₹4.11
Total Cash Flow	-₹12.73	₹70.49	₹6.57	-₹0.16
Cash (Start of the year)	₹78.02	₹7.53	₹0.96	₹1.12
Cash (End of the year)	₹65.29	₹78.02	₹7.53	₹0.96

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Non-Current Assets	₹1,359.21	₹1,230.66	₹1,124.49	₹1,101.54
Current Assets	₹1,227.51	₹1,151.12	₹1,119.48	₹919.07
Total Assets	₹2,586.72	₹2,381.78	₹2,243.97	₹2,020.61
Current Liabilities	₹690.12	₹609.87	₹559.75	₹455.91
Net Current Asset	₹537.39	₹541.25	₹559.73	₹463.16
Non-Current Liabilities	₹98.22	₹84.50	₹72.89	₹58.15
Equity Capital	₹1,798.38	₹1,687.41	₹1,611.33	₹1,506.55
Total Equity & Liabilities	₹2,586.72	₹2,381.78	₹2,243.97	₹2,020.61